An Efficacy and Safety Study for Epoetin Alfa (PROCRIT) in Cancer Patients Not Receiving Chemotherapy or Radiation
Clinical trial NCT00210587 · COMPLETED
Trial details
- NCT number
- NCT00210587
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-02-01
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.